Metabolic syndrome (MetS) in mid‐life is a known risk factor for Alzheimer’s disease & related dementias (ADRD). Racial and ethnic minorities represent under‐represented groups (URGs) in ADRD research. Targeted outreach, recruitment and retention initiatives broaden the reach of Alzheimer Disease Research Centers (ADRC) within prioritized communities. Understanding the association between MetS risk factors and cognition during preclinical ADRD in URGs may elucidate avenues for ameliorating ADRD risk in URGs prior to dementia onset. Generalizability of findings vary by the population represented within an analytic sample. We describe MetS‐cognition relationships within URGs and referral source, a key determinant of our sample composition.